Some popular drugs used to treat Type 2 diabetes have come under scrutiny after a new research indicates that some diabetes drugs may cause pancreatic changes that can lead to pancreatic cancer. The drugs studied were Januvia, Byetta and some other diabetes drugs often prescribed to patients in the U.S.
The diabetes drugs in question are used to increase the natural substances in a person’s body that help raise low blood sugar levels. These diabetes drugs are incretin mimetic drugs that try to imitate the body’s hormones to stimulate insulin release after a person eats and thousands of patients with Type 2 diabetes are prescribed this type of drug every year.
This is not the first time this type of diabetes drug has come under fire. Back in 2009, the Food and Drug Administration required that these drugs include a warning on their label about the risk of acute pancreatitis, which can not only be fatal but also be a risk factor for pancreatic cancer. The drugs have also been linked to causing other serious health complications, including low blood sugar, allergic reactions, thyroid cancer, nausea, anorexia, severe pain and even death.
Several lawsuits have already been filed against the manufacturers of these commonly prescribed drugs, with most plaintiffs alleging that they suffered pancreatitis and other painful injuries after taking the defective drugs.
Patients who take this type of drug to treat Type 2 diabetes may want to consult their physician about the serious side effects and impact taking the drug will have on their overall health. Patients who have suffered an injury after taking these diabetes drugs may be able to seek legal action against the manufacturer for manufacturing and selling defective and unsafe drugs.
Source: News Inferno, “Januvia, Byetta, Other Diabetes Drugs Focus of Controversy,” Cynthia A. Diaz-Shephard, May 31, 2013